Revive Therapeutics
Vaughan
About Revive Therapeutics
Revive Therapeutics Ltd. (TSX-V: RVV) (OTCQB: RVVTF) (FSE: 31R) is focused on the research, development and commercialization of novel therapies and technologies for the medical cannabis and cannabinoid pharmaceuticals markets by identifying and investigating potential therapies targeting the endocannabinoid system, such as cannabinoids, that may be repurposed for new indications, be delivered in a different way, combined with existing drugs, or be developed as new chemical entities.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $29.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2025)
- Ticker: cve:RVV
- Website: revivethera.com
- Phone: 905-605-5535
Industries & Categories
Cannabis, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/revive-therapeutics-170598 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.